An upcoming trial in Japan will mark the first time that induced pluripotent stem (iPS) cells have been used to treat spinal-cord injuries.
‘Reprogrammed’ stem cells to treat spinal-cord injuries for the first time
Approval from Japanese regulators means that trials of induced pluripotent stem cells can begin later this year.
go.nature.com
MHRA announces contingency legislation covering regulation of medicines and medical devices in a no-deal Brexit scenario #regulation #regulatorynews #Brexit -
Contingency legislation covering regulation of medicines and medical devices in a no deal scenario
Legislation has been published which, in the event of the UK leaving the EU with no agreement, will cover the regulation of medicines, medical devices...
ow.ly
